Dr. Marc Braunstein from NYU Langone joins the Healthcare Unfiltered EXPRESS to describe the recently published BRUIN-313 trial in frontline CLL and its potential impact on the treatment landscape for this disease. Check it out, subscribe, share, and join the conversation.

Dr. Ishwaria Subbiah joined the Healthcare Unfiltered EXPRESS to discuss burnout, a problem physicians and many other healthcare providers face. She offers that AI and technology may bring solutions to reduce this problem and improve satisfaction. Check it out, subscribe, review, share, and join the conversation.

Dr. Sara Tolaney of the Dana-Farber Cancer Institute joined the show to share her insights on the ASCENT-04 trial recently published in NEJM. This is an RCT in triple-negative breast cancer. Sara led this study and as the lead author, she puts its results in context - this is a must-listen episode. Please share, review, and subscribe.

Dr. Ajay Nooka of Emory University and the Winship Cancer Institute joins Healthcare Unfiltered EXPRESS to tell us about CELMoDs in multiple myeloma. What are these agents? How do they work? How do they help patients with myeloma? And what does the future of this disease look like now that we may have CELMoDs for this disease? A must listen, and please share your comments.

Dr. Kasi from the City of Hope joins the Healthcare Unfiltered EXPRESS for a chat on what intrigued him at the last ASCO GI meeting that took place a few weeks ago. What mattered and did any standards of care changed?

Take a listen, share, subscribe, review, and join the conversation.

Dr. Dan Olson of the University of Chicago joins the Healthcare Unfiltered EXPRESS to discuss the current state of TILs in cancer therapy, specifically in melanoma. Dr. Olson describes the technology, how to deliver, how to mitigate side effects, and offers valuable insights on future directions. A mist listen - please share, review, and subscribe.

Dr. Erika Hamilton from the SCRI joined the show to give timely and important updates on how treating breast cancer may be changing in view of trial data presented at the 2025 December SABCS meeting that just concluded. A must listen episode to stay up to date with new emerging data and therapies in breast cancer. Please share and subscribe.

Dr. Julio Chavez of the Mayo Clinic joins the Healthcare Unfiltered EXPRESS to explain data on this class of drugs, their mechanism of action, and where they fit in the treatment armamentarium of various lymphomas. The best way to stay up to date is to subscribe and share.